risk of malignancy due to intensive immunosuppressant treatment. 13 The cumulative incidences of ovarian cancer after kidney transplantation were 0.04%, 0.09%, and 0.14% at 12th-, 24th-, and 36th-month post-Tx, respectively. 14 The incidence of ovarian cancer is 0.26% in women after liver transplantation, and the incidence is much higher (15.4%, ie, 1:6.5)
in women with a previous history of breast cancer before Tx. 15 Impaired GFR and immunosuppressant-related malignancy often occur simultaneously in kidney and heart Tx. Therefore, the use of preventive assessments, including gynecological cancer prevention, is recommended in young post-transplant patients. We found positive ROMA with a higher frequency in women after Tx with negative specialist ultrasound examination and normal renal function compared to nontransplant, but polymorbid, women, which is in contrast to the clinical experience. Our study compared transplant and diseased nontransplant pairs of women and men matched by age and serum creatinine and assessed the role of different confounding factors influencing the reliability of HE4, CA125, and ROMA in solid organ transplant recipients.
| MATERIAL S AND ME THODS

| Patients
Our pilot study retrospectively evaluated 155 consecutive ROMA index results in 155 women with pelvic mass. Our cohort included 50 women after solid organ Tx (premenopausal status 72%) and 105 diseased women without organ transplantation (56% premenopausal). The transplanted organs were liver (16 patients), kidney (14 pts), combined kidney and pancreas (14 pts), heart (5 pts), and pancreas
(1 patient). Immunosuppressant regimens consisted primarily of tacrolimus (approximately 80% of patients) and everolimus, sirolimus, and rarely cyclosporin A, which was used to a lesser extent.
Our case-control study matched 202 women and 236 men by age and serum creatinine to eliminate the 2 main known factors that influence HE4
and ROMA. The purpose of the case-control study was not to assess the risk of malignancy, but to evaluate the confounding factors that influence levels of HE4 and CA125. The pair consisted of patients (woman or man) after solid organ transplantation and diseased, but nontransplant, patients matched by sex, age, and serum creatinine. The reliability of matching was assessed by calculating the relative differences between paired data.
Detailed analyses of relationships between HE4, CA125, creatinine, morbidity, and transplant status were performed for women only. The necessary criteria for inclusion, except for matched age and creatinine, were at least 1-year survival after Tx without any known gynecological malignancy (breast, ovary, cervix, and uterus). The transplanted organs were kidney (41), combined kidney and pancreas (21) , liver (29) , liver and kidney (2), liver and Langerhans islets (1), pancreas (3), and heart (4). Tacrolimus was used in 98 women (97%), 2 women were treated with cyclosporin, and 1
woman received a combination of cyclosporin and sirolimus.
| Clinical data
Clinical data of the women with transplants were retrieved from patient records. Information on diabetes mellitus, primary or secondary hyperparathyroidism, hypoparathyroidism, anemia, intestinal disease, lung disease, and ischemic heart disease was extracted from patient history. Information on the presence of hypertension or hyperlipidemia was derived from patient history or medications (antihypertensives or hypolipidemics). Infection was defined as any acute or chronic infection at the time of evaluation or when actual treatment with antibiotics was recorded. Tumor was defined as any malignant tumor (of nongynecological origin) in the patient history. Hypothyroidism and hyperthyroidism were derived from patient history or medications (actual treatment with hormonal supplementation or the use of thyreostatics). Nephropathy (kidney disease) was derived from patient history (in patients without renal Tx) or kidney transplantation.
Similarly, hepatopathy (liver disease) was derived from patient history (in patients without liver Tx) or liver transplantation.
| Laboratory methods
All measurements were performed in an accredited laboratory (accord- Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI 2012 creatinine formula according to the KDIGO 2012 Guidelines.
| Statistical evaluation
We used the Mann-Whitney test, Kruskal-Wallis test with Conover post hoc analysis, the Spearman's nonparametric coefficient of correlation, and Fisher's exact test.
| Ethics committee approval
The 
| RE SULTS
We present the data in 2 parts. The pilot study described the problem of possible false elevations of HE4 and ROMA in women after transplantation. The case-control study analyzed the results of HE4 and CA125 measured in women and men with and without transplantation, who were matched by age and serum creatinine. We also focused on the relationship between post-transplant clinical status, immunosuppressant therapy, and tested biomarkers (HE4, CA125).
| Pilot study
There were significant correlations between serum creatinine and HE4 (r = .545, P < .0001, N = 155) and between serum creatinine and ROMA (r = .525, P < .0001). However, only a weak correlation was found between serum creatinine and CA125 (r = .170, P < .05), while age did not correlate to ROMA, HE4, or CA125.
We further divided the group of women into tertiles (T1-T3) based on the concentration of serum creatinine. Table 1 summarizes these results.
We compared ROMA with specific cutoff limits for increased risk of epithelial ovarian cancer to assess the risk of malignancy. The cutoffs of 11.4% and 29.9% were used for premenopausal and postmenopausal women, respectively. A significantly higher proportion of cases with increased risk of cancer were found in women after transplantation compared to that of the non-Tx cohort (OR 18.2, 95% CI 7.7-43.4, only slightly correlated to HE4 (r = .250, P < .005) but not CA125.
Similarly, the correlation between serum creatinine and CA125 was also low (r = .227, P < .01).
Similar relationships were found in men. HE4, but not CA125, and creatinine correlated significantly (r = .848, P < .0001, N = 236). Similarly, HE4, but not CA125, slightly correlated with age (r = .240, P < .0005). Table 3 compares the values of measured variables in tertiles (T1-T3) of serum creatinine. Values of HE4 increased significantly with increasing serum creatinine and decreasing eGFR (Kruskal-Wallis test, P < .0001), and post hoc analysis revealed significant differences in HE4 concentrations between respective tertiles. HE4 in T2 was significantly higher than HE4 in T1 (P < .05), and HE4 in T3 was significantly higher than HE4 in T2 (P < .05). The increase in CA125 with increasing creatinine was significant (P = .0052), but CA125 concentrations in T3 were significantly higher than CA125 in T1 only (P < .05).
Similar results (ie, increasing concentrations of HE4 with the decrease in GFR) were found in the case-control study in men (Table S1, online only).
We combined the tertiles of age and serum creatinine to demonstrate differences in HE4 in respective subgroups to further examine the relationships between HE4, age, and creatinine. Figure 1 displays these relationships.
An almost identical relationship between HE4 and tertiles of age and serum creatinine was found in men ( Figure S1 ).
The relationship between serum creatinine, age, and HE4 for all patients is also highlighted in Figures S3 and S4 . We confirmed the relationship between serum creatinine and HE4, which was statistically (r = .847, P < .0001) and clinically significant. However, the statistically significant relationship between age and HE4 (r = .309, P < .0001) likely exerted negligible clinical impact.
| The influence of post-transplant clinical status on HE4 and CA125
Figure 2 compares HE4 concentrations in women after transplantation (+) and without transplantation (x) in respective tertiles of serum creatinine.
We present data of measured variables in 2 subgroups with respect to the upper reference limit of serum creatinine to eliminate the strong influence of impaired renal function (represented by heavily increased serum creatinine) on HE4 values (Table 4 ). HE4
(P < .0001) and CA125 (P = 
| Relationship between tacrolimus, HE4, and CA125
We examined the relationship between the concentration of tacrolimus (used in 98 of 101 women and in all men after Tx) and HE4 or CA125. No significant relationship (Spearman r) between tacrolimus and HE4 was found in women or men. However, there was a significant but weak relationship between tacrolimus and CA125 in women (r = .238, P = .018) but not in men.
| Clinical data
We analyzed differences in clinical data in non-Tx and Tx women in the case-control study. Table 5 summarizes data for all women and women with normal concentrations of serum creatinine (up to 1.02 mg/dL [90 μmol/L]). Anemia, hyperparathyroidism, kidney, liver, and lung diseases were more frequent in the group of women after transplantation (P < .05). In a subset of women with serum creatinine in reference range, a significantly higher occurrence of anemia (P = .017), hyperparathyroidism (P = .026), kidney disease (P = .0029), and liver disease (P = .00003) was found in women after transplantation.
| D ISCUSS I ON
We confirmed increased HE4 concentrations in women and men with decreased eGFR and increased serum creatinine. However, TA B L E 3 Case-control study Data on the frequency of ovarian cancer in women with transplants are inconsistent with different rates in other studies. [16] [17] [18] HE4, CA125, and ROMA are the best predictors of malignancies in women with pelvic mass. However, ROMA is falsely increased in patients with decreased eGFR and/or increased creatinine 9, 10, 19 because of the higher HE4 concentrations in renal failure. Age, smoking, BMI, and menstrual status also influence HE4. 8, 19 There are likely other factors influencing the concentrations of HE4, CA125, and ROMA.
Shin et al 20 found falsely elevated ROMA in women with confirmed ovarian endometrioma, which was likely due to the elevated serum HE4.
| Pilot study
The significant relationships between serum creatinine, HE4, and ROMA in the pilot study are consistent with data in the literature.
However, there were also increased values of HE4, CA125, and ROMA in the group of women with transplants with serum creatinine within the reference range, despite the younger age of this cohort (Table 1) . Therefore, serum creatinine may be the major factor contributing to the differences in HE4 and ROMA between women with and without transplants. (Table 2) . Therefore, the difference in the concentration of HE4 between women with and without transplants is determined by factors other than decreased renal function. Four women without transplants with the highest concentrations of HE4 were dialyzed polymorbid patients who were on a waiting list for kidney Tx. Therefore, their classification as nontransplant is correct, but the very high concentration of creatinine is the primary cause of the increased HE4.
| Case-control study
The purpose of our case-control study was to assess possible confounders in selected pairs of women and men matched by age and serum creatinine, but not to use HE4 and ROMA for detection of malignancies. HE4 increased with higher concentrations of serum creatinine in women and men (Table 3 and Table S1 ). The differences in HE4 between tertiles of serum creatinine were highly significant.
The relationship between HE4 and creatinine was more pronounced than the relationship between HE4 and age ( Figure 1 and Figure S1 ).
In women, CA125 was significantly higher only in the 3rd tertile of serum creatinine compared to the 1st tertile. There was no relationship between CA125 and creatinine in men. It is advisable to measure serum creatinine or serum cystatin C consistently to detect even mild kidney disease before examinations of HE4, CA125, and ROMA are requested. 11 The use of the CKD-EPI equation played a limited role compared to that of serum creatinine, which was likely because of the incorporation of age in the equation.
The clinical situation of the patient should always be analyzed. Risky, polymorbid patients with chronic diseases and patients after solid organ transplantation may display higher HE4 concentrations, even within the reference values of serum creatinine and a younger age group.
An ultrasound in expert hands is a superior tool to tumor markers for the diagnosis and differential diagnosis of pelvic tumors in The difference between women with and without transplants was tested using Fisher's exact test. Data are given both for all women (N = 202) and for subset of women (N = 72) with serum creatinine up to 1.02 mg/dL (90 μmol/L).
TA B L E 4 Women: Case-control study patients with increased serum creatinine levels (>1.02 mg/dL) and in patients after transplant. However, the prognostic potential of HE4 can be diminished by many confounding factors, while the data on diagnostic efficacy in patients after solid organ transplantation are scarce.
| CON CLUS IONS
Serum creatinine influenced HE4 much more than age in women and men. However, the concentration of HE4 was significantly higher in polymorbid women after kidney, liver, pancreas, and heart trans- 
| Study limitations
We did not analyze menstrual status in paired women matched by age and creatinine because we analyzed women and men. Some younger women were on contraceptives, and older women used hormonal replacement therapy. We were unable to analyze patient medication in details, except immunosuppressant therapy.
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